Literature DB >> 1408756

Gilvocarcin V exhibits both equilibrium DNA binding and UV light induced DNA adduct formation which is sequence context dependent.

R M Knobler1, F B Radlwimmer, M J Lane.   

Abstract

The relative degree of both equilibrium binding and of ultraviolet light induced adduct formation for the antitumor antibiotic gilvocarin V with two hexaecamer DNA sequence isomers, d[ATATATAGCTATATAT]2 and d[AAAAAAAGCTTTTTTT]2, was assessed. The experiments reveal that gilvocarin V binds, under equilibrium conditions, and reacts, in the presence of exogenously applied UV light, more efficiently with the alternating purine:pyrimidine sequence hexadecamer than the homopurine:homopyrimidine duplex at identical gilvocarcin V to DNA duplex ratios. DNAse I digests of adduct containing duplexes derived from the d[AAAAAAAGCTTTTTTT]2 duplex, identified and isolated using gel shift assays employing denaturing polyacrylamide gels, confirm that gilvocarcin V adducts can be formed with thymine residues but suggest that adduct formation with either adenine or guanine residues is also possible.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1408756      PMCID: PMC334184          DOI: 10.1093/nar/20.17.4553

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  10 in total

Review 1.  Cutaneous T cell lymphoma.

Authors:  R M Knobler; R L Edelson
Journal:  Med Clin North Am       Date:  1986-01       Impact factor: 5.456

2.  Structural specificities of five commonly used DNA nucleases.

Authors:  H R Drew
Journal:  J Mol Biol       Date:  1984-07-15       Impact factor: 5.469

3.  The effects of gilvocarcin V and ultraviolet radiation on pBR322 DNA and lymphocytes.

Authors:  F P Gasparro; R M Knobler; R L Edelson
Journal:  Chem Biol Interact       Date:  1988       Impact factor: 5.192

4.  Sequence specificity of actinomycin D and Netropsin binding to pBR322 DNA analyzed by protection from DNase I.

Authors:  M J Lane; J C Dabrowiak; J N Vournakis
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

5.  Antitumor agents from Streptomyces anandii: gilvocarcins V, M and E.

Authors:  D M Balitz; F A O'Herron; J Bush; D M Vyas; D E Nettleton; R E Grulich; W T Bradner; T W Doyle; E Arnold; J Clardy
Journal:  J Antibiot (Tokyo)       Date:  1981-12       Impact factor: 2.649

6.  Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial.

Authors:  A H Rook; B Freundlich; B V Jegasothy; M I Perez; W G Barr; S A Jimenez; R L Rietschel; B Wintroub; M B Kahaleh; J Varga
Journal:  Arch Dermatol       Date:  1992-03

7.  Extracorporeal photochemotherapy induces the production of tumor necrosis factor-alpha by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis.

Authors:  B R Vowels; M Cassin; M H Boufal; L J Walsh; A H Rook
Journal:  J Invest Dermatol       Date:  1992-05       Impact factor: 8.551

8.  An ESR study of the visible light photochemistry of gilvocarcin V.

Authors:  A E Alegria; C M Krishna; R K Elespuru; P Riesz
Journal:  Photochem Photobiol       Date:  1989-03       Impact factor: 3.421

9.  Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus. A pilot study.

Authors:  R M Knobler; W Graninger; W Graninger; A Lindmaier; F Trautinger; J S Smolen
Journal:  Arthritis Rheum       Date:  1992-03

10.  Light-induced modifications of DNA by gilvocarcin V and its aglycone.

Authors:  Y C Tse-Dinh; L R McGee
Journal:  Biochem Biophys Res Commun       Date:  1987-03-30       Impact factor: 3.575

  10 in total
  6 in total

1.  Enzymatic methylation and structure-activity-relationship studies on polycarcin V, a gilvocarcin-type antitumor agent.

Authors:  Jhong-Min Chen; Micah D Shepherd; Jamie Horn; Markos Leggas; Jürgen Rohr
Journal:  Chembiochem       Date:  2014-11-03       Impact factor: 3.164

2.  Engineered biosynthesis of gilvocarcin analogues with altered deoxyhexopyranose moieties.

Authors:  Micah D Shepherd; Tao Liu; Carmen Méndez; Jose A Salas; Jürgen Rohr
Journal:  Appl Environ Microbiol       Date:  2010-11-12       Impact factor: 4.792

3.  The crystal structure and mechanism of an unusual oxidoreductase, GilR, involved in gilvocarcin V biosynthesis.

Authors:  Nicholas Noinaj; Mary A Bosserman; M Alexandra Schickli; Grzegorz Piszczek; Madan K Kharel; Pallab Pahari; Susan K Buchanan; Jürgen Rohr
Journal:  J Biol Chem       Date:  2011-05-10       Impact factor: 5.157

4.  GilR, an unusual lactone-forming enzyme involved in gilvocarcin biosynthesis.

Authors:  Madan Kumar Kharel; Pallab Pahari; Hui Lian; Jürgen Rohr
Journal:  Chembiochem       Date:  2009-05-25       Impact factor: 3.164

5.  The complete gene cluster of the antitumor agent gilvocarcin V and its implication for the biosynthesis of the gilvocarcins.

Authors:  Carsten Fischer; Fredilyn Lipata; Jürgen Rohr
Journal:  J Am Chem Soc       Date:  2003-07-02       Impact factor: 15.419

6.  Inactivation of the ketoreductase gilU gene of the gilvocarcin biosynthetic gene cluster yields new analogues with partly improved biological activity.

Authors:  Tao Liu; Madan K Kharel; Lili Zhu; Samuel A Bright; Cynthia Mattingly; Val R Adams; Jürgen Rohr
Journal:  Chembiochem       Date:  2009-01-26       Impact factor: 3.164

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.